logo
Select company
Select metric
$ 0.01EBIT per Share
VS
Market
40
Sector
78
Industry
90
History
100
$ 1.29Close
$ 1.06 - $ 2.55 52-Week Range
Ticker Information

Ticker

HRTX

Company Name

HERON THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

HERON THERAPEUTICS INC - EBIT per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HRTX - EBITPS Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT per ShareShare FactorWeighted Average Shares
6/30/2025$ 1.55M$ 0.011154.02M
3/31/2025$ -5.3M$ -0.031153.49M
12/31/2024$ -11.1M$ -0.071152.45M
9/30/2024$ -27.46M$ -0.181152.83M
6/30/2024$ -47.62M$ -0.311152.31M
3/31/2024$ -80.45M$ -0.531151.2M
12/31/2023$ -110.06M$ -0.81138.13M
9/30/2023$ -118.87M$ -0.821144.99M
6/30/2023$ -135.77M$ -1.131119.72M
3/31/2023$ -150.07M$ -1.261119.25M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HERON THERAPEUTICS INC's latest trailing twelve months (TTM) EBITPS stands at $ -2.52.
  • Over the past 5 years, HERON THERAPEUTICS INC's average EBITPS has been $ -1.38.
  • The median EBITPS for HERON THERAPEUTICS INC during this period was $ -1.46
  • HERON THERAPEUTICS INC reached its highest EBITPS over the past 5 years at $ 0.01.
  • The lowest EBITPS recorded by HERON THERAPEUTICS INC in the same timeframe $ -2.52

HERON THERAPEUTICS INC's EBITPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITPS Benchmarks
CompanyEBITPS
GLUE : MONTE ROSA THERAPEUTICS INC $ 0.35CHRS : COHERUS ONCOLOGY INC $ 1.68TRDA : ENTRADA THERAPEUTICS INC $ -1.86MGNX : MACROGENICS INC $ -0.55VNDA : VANDA PHARMACEUTICALS INC $ -1.44AGEN : AGENUS INC $ -2.95IGMS : IGM BIOSCIENCES INC $ -0.87OSUR : ORASURE TECHNOLOGIES INC $ -0.64ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -2.79ALEC : ALECTOR INC $ -1.15

Definition of EBIT per Share

[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for HERON THERAPEUTICS INC is calculated as follows: EBIT [ $ -228.7M ] / (Shares WA [ 90.85M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -2.52 ]

HRTX - EBIT per Share, Last 5 years

$ -2.52

Minimum

Dec 31, 2020

$ 0.01

Maximum

Jun 30, 2025

$ -1.38

Average

$ -1.46

Median

EBITPS Benchmark Analysis

The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.41.
The following table provides additional summary stats:
EBITPS in the Market:
filtered constituents3.79K
min$ -9.71
max$ 10.76
average$ 1.16
median$ 0.39
std$ 3.41